Sensorium Therapeutics is a clinical-stage biotechnology company developing next-generation brain and mental health medicines inspired by nature and powered by AI, chemistry, and neuroscience. Its proprietary SensAI™ platform mines vast biological and ethnobotanical data to identify and optimize nature-derived molecules with therapeutic potential in central nervous system disorders. The company’s pipeline includes first-in-class programs targeting anxiety and other neuropsychiatric conditions, with lead assets advancing toward clinical development.

VISIT WEBSITE